Ni-Q

What Ni-Q does

Ni-Q is a Wilsonville, Oregon-based medical nutrition company that supplies shelf-stable human donor milk (HDM) under its HDM Plus™ brand for premature, low birth weight, and otherwise at-risk infants when a mother's own milk is unavailable. The company processes donated breast milk sourced from nursing mothers across all 50 U.S. states, compensating donors at $1 per ounce.

Ni-Q's core product differentiation rests on two patent-pending technologies: Agitated Retort Processing, an advanced pasteurization method that eliminates bacteria and viruses (including Bacillus Cereus) that traditional Holder pasteurization does not fully eradicate, and a Guaranteed Caloric Standardization System that delivers a minimum of 20 calories per ounce. HDM Plus is triple-tested for safety (donor screening, pre-production forensic-level testing of every donation, and third-party post-production nutritional validation via Eurofins DQCI), homogenized to prevent feeding line clogging, and stabilized for up to 12 months at room temperature with a 5-day post-opening refrigerated use window. Approximately 15% of received donor milk is rejected during pre-production safety testing. The company holds FDA approval for its handling and pasteurization processes.

Ni-Q commercializes through two go-to-market motions: enterprise field sales to hospitals, NICUs, and pediatric care facilities, supported by pilot programs and direct clinician outreach, and a Direct-to-Family e-commerce channel for home use. Pricing is quote-based and not publicly disclosed, with multi-year hospital contracts as the implied standard. Founded around 2014-2015, the company has operated for over a decade and reported a single disclosed funding round of approximately $2.82M in 2017; named leaders include CEO Bill Pfost and President Bill Houston. The company is structured as an Oregon LLC and operates as a private for-profit entity.

Name

Ni-Q

Legal name

Ni-Q, LLC

Website

https://ni-q.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Ni-Q is an Oregon-based medical nutrition company that produces HDM Plus™, a patented shelf-stable human donor milk pasteurized via Agitated Retort Processing and standardized to 20 calories per ounce for premature and at-risk infants. It sells to U.S. hospitals, NICUs, and pediatric clinics through enterprise field sales and directly to families via e-commerce.

Ownership category

akta.pro rank

Product category

Human Donor Milk

NAICS

Dairy Product (except Frozen) Manufacturing (31151), Dairy Product Manufacturing (3115)

SIC

Dairy Products (2020)

akta.pro primary industry

Special Medical Purpose Infant Formula Manufacturing (FSMP/Medical Nutrition) (AFAHAHAC)

akta.pro secondary industries

Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ), Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins) (CRADAEAI)

Keywords

• Human donor milk
• Neonatal nutrition products
• Pasteurized donor milk
• NICU feeding supply
• Breast milk processing

Headquarters

HQ city

Wilsonville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. HDM Plus Product Sales: Ni-Q generates revenue through the sale of HDM Plus human donor milk products to hospitals, healthcare facilities, and families. Products are sold in boxes of 48 pouches (4 oz each). The company provides compensation to milk donors at $1/oz.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Ni-Q manufactures and sells HDM Plus™, a premium shelf-stable pasteurized human donor milk product standardized to 20 calories per ounce for premature and at-risk infants in hospital NICU, pediatric care, and home settings. The product is processed using proprietary Agitated Retort Processing with triple-testing protocols and is sold in boxes of 48 pouches (4 oz each) through B2B sales to healthcare facilities and B2C direct-to-family e-commerce. Ni-Q sources donor milk from nursing mothers across all 50 U.S. states and compensates donors at $1 per ounce.

Product overview

Ni-Q offers a single core product, HDM Plus™, which is a premium shelf-stable human donor milk for at-risk infants. The company provides hospital-grade, pasteurized donor milk that is triple-tested for safety, standardized to 20 calories per ounce, and ready-to-feed without freezing. HDM Plus comes in 4 oz pouches (48 per box) and is designed for both hospital NICU settings and direct-to-family use. The product differentiates through its advanced pasteurization process (Agitated Retort Processing), homogenization, extended post-opening usability (5 days refrigerated), and guaranteed nutritional levels with third-party validation.

Differentiator

Problem solved

Functional benefit

Brands

• HDM Plus™: Premium human donor milk product - the only 20-calorie shelf-stable donor milk on the market. Triple-tested, pasteurized, and guaranteed to deliver 20 cals/oz. Can be used up to 5 days after opening with refrigeration.

Products and services

• HDM Plus™

Quantifiable outcome

• Guaranteed minimum 20 calories per ounce vs. 13.1-16.6 cal/oz variability in frozen HDM
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• St. Jude FoundationminorOthersNi-Q proudly supports the work of the St. Jude Children's Research Hospital through charitable contributions, demonstrating corporate social responsibility in pediatric healthcare.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Prolacta Bioscience: Prolacta is the leading commercial processor of human donor milk for premature infants in the NICU, offering standardized human milk–based fortifiers and products. It is the closest direct competitor to Ni-Q's HDM Plus, competing on safety, standardization, and hospital contracts in the same clinical segment.
• Medolac Laboratories: Medolac develops shelf-stable human donor milk products for hospital and infant nutrition use, overlapping directly with Ni-Q on format (non-frozen) and customer (NICUs). Both companies compete on shelf stability and pathogen-elimination claims versus frozen community milk banks.

Regional players

• Danone (Nutricia): Danone's Nutricia division markets specialized infant nutrition (e.g., Neocate, Infatrini) with strong presence in Europe and growing presence in the U.S. preterm segment. It is comparable as an international incumbent in specialized infant medical nutrition that Ni-Q does not yet address.

Emerging players

• Bobbie: Bobbie is an emerging U.S. infant formula brand focused on premium, organic, and European-style formulations targeting parents seeking alternatives to standard formula. While not a human donor milk competitor, Bobbie competes for the same premium-conscious parent wallet share as Ni-Q's DTC channel.
• Prolacta / MommyFirst: Prolacta-affiliated direct-to-consumer donor milk offerings represent an emerging commercial channel competing with Ni-Q's Direct-to-Family motion, particularly for parents of premature infants post-discharge.
• ByHeart: ByHeart is a venture-backed infant formula startup with vertically integrated manufacturing and a focus on whole-milk-based formulations. It is an adjacent emerging competitor for premium infant nutrition customers, including families who might otherwise consider donor milk at home.

Broad incumbents

• Nestlé Health Science: Nestlé Health Science offers specialized medical nutrition products, including preterm infant formulas and human milk fortifiers. As a broad incumbent in medical nutrition, it competes for NICU formulary budgets and represents a potential acquirer or disruptor for Ni-Q's niche.
• Human Milk Banking Association of North America (HMBANA): HMBANA is the umbrella network of non-profit milk banks supplying the majority of hospital donor milk in North America. Ni-Q competes directly against HMBANA-affiliated banks on hospital contracts, though HMBANA operates on a non-profit cost-plus model rather than as a commercial premium supplier.
• Abbott Nutrition (Similac): Abbott's Similac line dominates the U.S. infant formula market, including premature-infant formulations (e.g., Similac NeoSure). As a broad incumbent, Abbott competes indirectly for the same at-risk infant nutrition budget that Ni-Q addresses with HDM Plus.
• Reckitt (Mead Johnson / Enfamil): Reckitt's Mead Johnson division produces the Enfamil line, including Enfamil Premature and human milk fortifiers, and is the other dominant incumbent in NICU infant nutrition alongside Abbott. It competes with Ni-Q for hospital formulary inclusion and for parent adoption post-discharge.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ni-Q